Drug profile · INN
metreleptin
MYALEPTA
metreleptin (MYALEPTA) is a leptin receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — metreleptin
- US status
- approved
- Class
- Alimentary tract and metabolism (A16)
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
metreleptin (MYALEPTA) is a leptin receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Leptin receptor agonist
Primary target: Leptin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is metreleptin?
metreleptin (MYALEPTA) is a leptin receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for metreleptin?
MYALEPTA is a marketed brand name for metreleptin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metreleptin?
metreleptin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.